Arcoma AB (Sweden) Technical Analysis
| ARCOMA Stock | SEK 7.50 0.46 5.78% |
As of the 21st of February, Arcoma AB shows the risk adjusted performance of 0.0167, and Mean Deviation of 2.14. Arcoma AB technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Arcoma AB Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Arcoma, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ArcomaArcoma |
Arcoma AB 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Arcoma AB's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Arcoma AB.
| 11/23/2025 |
| 02/21/2026 |
If you would invest 0.00 in Arcoma AB on November 23, 2025 and sell it all today you would earn a total of 0.00 from holding Arcoma AB or generate 0.0% return on investment in Arcoma AB over 90 days. Arcoma AB is related to or competes with Scibase AB, Biosergen, Iconovo, Luxbright, Neola Medical, Nanologica, and Biovica International. Arcoma AB develops, produces, and provides radiology solutions worldwide More
Arcoma AB Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Arcoma AB's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Arcoma AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.47 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 14.27 | |||
| Value At Risk | (3.95) | |||
| Potential Upside | 5.63 |
Arcoma AB Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Arcoma AB's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Arcoma AB's standard deviation. In reality, there are many statistical measures that can use Arcoma AB historical prices to predict the future Arcoma AB's volatility.| Risk Adjusted Performance | 0.0167 | |||
| Jensen Alpha | 0.0481 | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | (0.07) |
Arcoma AB February 21, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0167 | |||
| Market Risk Adjusted Performance | (0.06) | |||
| Mean Deviation | 2.14 | |||
| Semi Deviation | 2.29 | |||
| Downside Deviation | 2.47 | |||
| Coefficient Of Variation | 8147.21 | |||
| Standard Deviation | 2.82 | |||
| Variance | 7.98 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | 0.0481 | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | (0.07) | |||
| Maximum Drawdown | 14.27 | |||
| Value At Risk | (3.95) | |||
| Potential Upside | 5.63 | |||
| Downside Variance | 6.09 | |||
| Semi Variance | 5.25 | |||
| Expected Short fall | (2.65) | |||
| Skewness | 0.8649 | |||
| Kurtosis | 1.71 |
Arcoma AB Backtested Returns
At this point, Arcoma AB is slightly risky. Arcoma AB secures Sharpe Ratio (or Efficiency) of 0.0314, which signifies that the company had a 0.0314 % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Arcoma AB, which you can use to evaluate the volatility of the firm. Please confirm Arcoma AB's mean deviation of 2.14, and Risk Adjusted Performance of 0.0167 to double-check if the risk estimate we provide is consistent with the expected return of 0.0909%. Arcoma AB has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.33, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Arcoma AB are expected to decrease at a much lower rate. During the bear market, Arcoma AB is likely to outperform the market. Arcoma AB right now shows a risk of 2.89%. Please confirm Arcoma AB coefficient of variation, semi variance, period momentum indicator, as well as the relationship between the treynor ratio and daily balance of power , to decide if Arcoma AB will be following its price patterns.
Auto-correlation | 0.11 |
Insignificant predictability
Arcoma AB has insignificant predictability. Overlapping area represents the amount of predictability between Arcoma AB time series from 23rd of November 2025 to 7th of January 2026 and 7th of January 2026 to 21st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Arcoma AB price movement. The serial correlation of 0.11 indicates that less than 11.0% of current Arcoma AB price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.11 | |
| Spearman Rank Test | -0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 0.05 |
Arcoma AB technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Arcoma AB Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Normalized Average True Range is used to analyze tradable apportunities for Arcoma AB across different markets.
About Arcoma AB Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Arcoma AB on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Arcoma AB based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Arcoma AB price pattern first instead of the macroeconomic environment surrounding Arcoma AB. By analyzing Arcoma AB's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Arcoma AB's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Arcoma AB specific price patterns or momentum indicators. Please read more on our technical analysis page.
Arcoma AB February 21, 2026 Technical Indicators
Most technical analysis of Arcoma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Arcoma from various momentum indicators to cycle indicators. When you analyze Arcoma charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0167 | |||
| Market Risk Adjusted Performance | (0.06) | |||
| Mean Deviation | 2.14 | |||
| Semi Deviation | 2.29 | |||
| Downside Deviation | 2.47 | |||
| Coefficient Of Variation | 8147.21 | |||
| Standard Deviation | 2.82 | |||
| Variance | 7.98 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | 0.0481 | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | (0.07) | |||
| Maximum Drawdown | 14.27 | |||
| Value At Risk | (3.95) | |||
| Potential Upside | 5.63 | |||
| Downside Variance | 6.09 | |||
| Semi Variance | 5.25 | |||
| Expected Short fall | (2.65) | |||
| Skewness | 0.8649 | |||
| Kurtosis | 1.71 |
Arcoma AB February 21, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Arcoma stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 3,702 | ||
| Daily Balance Of Power | (0.47) | ||
| Rate Of Daily Change | 0.94 | ||
| Day Median Price | 7.49 | ||
| Day Typical Price | 7.49 | ||
| Price Action Indicator | (0.22) |
Complementary Tools for Arcoma Stock analysis
When running Arcoma AB's price analysis, check to measure Arcoma AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcoma AB is operating at the current time. Most of Arcoma AB's value examination focuses on studying past and present price action to predict the probability of Arcoma AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcoma AB's price. Additionally, you may evaluate how the addition of Arcoma AB to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |